Tracy Garcia turned the second bedroom of her Oakland apartment into a fashion studio, where repurposed clothes become works ...
Karen is a writer and editor with more than 25 years of print and digital media experience working in newspapers, educational publishing, marketing, nonprofits, and magazines. A stack of microfiber ...
Grace Cooper is a writer who specializes in shopping. Her work has appeared in The Kitchn, Apartment Therapy, Culinary Hill, and more. I recently started making sourdough bread — or at least ...
Jake Valentine is a Contributor at DualShockers with more than two decades of experience covering the video game industry. Since 2004, he has written about games across news, reviews, guides, lists, ...
Bubsy 4D Is A Fun Platformer Throwback That Can’t Escape The Genre’s Historic Struggles [Review]
Fun platforming gameplay offers a natural sense of movement. Wonky camera angles can throw off the experience. Solid controls and clever challenges are a joy for fans of 3D platformers. Relatively ...
Harkins Theatres is bringing a whole new movie-watching experience to its theaters later this summer. The Arizona theater chain is partnering up with Lumma 4D E-Motion to equip Harkins theaters with a ...
Windows 11 is available for download worldwide. Microsoft has released it as a free upgrade, which means you do not need to pay to upgrade your computer to Windows 11. It is available for free ...
Bubsy 4D will launch for PlayStation 5, Xbox Series, Switch 2, PlayStation 4, Xbox One, Switch, and PC via Steam, Epic Games Store, and GOG on May 22 for $19.99, publisher Atari and developer Fabraz ...
Katie has a PhD in maths, specializing in the intersection of dynamical systems and number theory. She reports on topics from maths and history to society and animals. Katie has a PhD in maths, ...
Publisher Atari and developer Fabraz have announced Bubsy 4D for PlayStation 5, Xbox Series, Switch 2, PlayStation 4, Xbox One, Switch, and PC (Steam, Epic Games Store, GOG). A release date was not ...
4D Molecular Therapeutics has posted 60-week data on a gene therapy, providing evidence of durability in diabetic macular edema (DME) and sending its stock up more than 40% in premarket trading. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results